key: cord-0811102-6k4c6zei
authors: Rogo, Tanya; Mathur, Kanika; Purswani, Murli
title: Systemic Inflammation With Cardiac Involvement in Pediatric Patients With Evidence of COVID-19 in a Community Hospital in the Bronx, New York
date: 2020-07-20
journal: J Pediatric Infect Dis Soc
DOI: 10.1093/jpids/piaa087
sha: 1ac23356d329f9149c8a326b4789c6999beaf4cf
doc_id: 811102
cord_uid: 6k4c6zei

nan

To the Editor-On April 27, 2020, the Paediatric Intensive Care Society of the United Kingdom reported cases of critically ill children presenting with features of Kawasaki disease or toxic shock syndrome, associated with coronavirus disease 2019 (COVID-19). Subsequent case definitions for the multisystem inflammatory syndrome in children associated with COVID-19 have been released [1, 2] . New York City (NYC) has had the largest burden of COVID-19 cases in the United States, with the Bronx borough experiencing the highest rate of infections (2766 per 100 000) [3] . Our initial clinical experience of mostly mild COVID-19 illness in children changed with the presentation of children with systemic inflammation and cardiac involvement, all of whom tested negative at presentation for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by polymerase chain reaction (PCR), with subsequent positive antibody testing. We present 4 patients who presented over a 2-week period (April 26-May 11, 2020).

All patients had fever, and 3 patients (patients 1, 2, and 4) presented with gastrointestinal symptoms and tachycardia (Table 1) . None had respiratory symptoms or features of Kawasaki disease. Only one had a known contact with a confirmed COVID-19 case. Laboratory investigations showed signs of systemic inflammation with increased levels of C-reactive protein and ferritin, but normal procalcitonin levels. Peripheral white blood cell counts revealed lymphopenia in all patients. All had elevated troponin and pro-brain natriuretic peptide levels. Two patients (patients 2 and 3) had features of clinical myocarditis (markedly elevated troponin and decreased ejection fraction on echocardiography). All patients were transferred to pediatric cardiac centers. Patient 1 developed refractory vasoplegic shock on his second day of admission, necessitating transfer for mechanical circulatory support. Patient 2 was also transferred for mechanical circulatory support in the setting of severely depressed myocardial function. After the learned experience of rapid clinical deterioration, subsequent patients presenting to our emergency department with high suspicion of COVID-19 have had prompt cardiac investigations with electrocardiography and cardiac biomarkers.

These cases highlight the challenge for physicians assessing pediatric patients presenting with symptoms of fever and gastrointestinal illness. In addition to the standard differential diagnoses of bacterial sepsis, gastroenteritis, and acute abdomen, multisystem inflammatory syndrome with myocardial involvement must also be considered, even with negative SARS-CoV-2 PCR results. We report a wide range of cardiac involvement in children with documented COVID-19, including valvulitis, myocarditis, and shock. We propose that in addition to simultaneous SARS-CoV-2 PCR and antibody testing, inflammatory markers, cardiac enzymes, and electrocardiography should be considered in lymphopenic pediatric patients presenting with fever, significant tachycardia, and gastrointestinal symptoms in areas with widespread community transmission of COVID-19. Prompt referral to an advanced pediatric cardiac center should be considered if myocardial involvement is suspected, as clinical deterioration can be rapid. Alinity i SARS-CoV-2 IgG (Abbott). c Coronary artery assessments for patient 1 and 2 were not performed as they were clinically unstable at the time of initial cardiology assessment.

Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease

2020 health advisory #16: updated reporting requirements for multisystem inflammatory syndrome in children associated with COVID-19 (formerly pediatric multisystem inflammatory syndrome)

COVID-19: data